跳至主要内容
临床试验/NCT03203239
NCT03203239招募中不适用

Vasodilatory Effects of Light on Peripheral Artery Disease

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年1月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Changes in blood flow

研究概览

简要总结

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (<.9 or >1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above the gastrocnemius muscle. Blood flow will be measured by infusion of ultrasound contrast and subsequent acquisition of ultrasound images. 2 blood samples will be collected for measurement of nitric oxide metabolites.

详细描述

The intent of this protocol is to measure blood flow in the gastrocnemius muscle in patients with documented peripheral artery disease before and after exposure to 670 nm light energy. The study consists of one visit. Blood flow measurement will be performed using contrast enhanced ultrasound, a method by which ultrasound contrast is continuously infused into the blood stream. Ultrasound records images in the area of interest and flow is related to the intensity of the contrast in each image. Blood will be drawn to measure nitric oxide metabolites. The study is designed to consist of one visit. However, if the protocol changes or the data quality initially collected is uninterpretable, subjects may be asked to return to allow for a standard methodology across all participants. In this case, the subjects who are asked to return will be subject to the same informed consent process a second time. The two visits will be at least one week apart to further reduce the already minimal risks of the study. This will also limit the number of study participants required to gather the necessary data to complete the study, thereby limiting the risks of the study to a smaller number of participants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants will be subjects between the ages of 18 and 85 who have been diagnosed with peripheral artery disease. Men and women will be recruited for participation. All ethnicities will be included in this study.
  • Diagnosis of peripheral artery disease is defined as an Ankle Brachial index of <0.9 or greater than 1.1 either at rest or during treadmill exercise.

排除标准

  • Exclusionary criteria include age under 18 years and over 85 years, those who are unable to understand the consent process , those who cannot read or speak English, active pregnancy, hypersensitivity to perflutren contrast agents, pulmonary hypertension, active illicit drug use, untreated blood pressure over 160/95, sickle cell disease, or a history of intracardiac shunt. Additional exclusion criteria neurological diseases such as spinal stenosis, unspecified pain disorders, and any uncontrolled medical conditions.

研究组 & 干预措施

Red Light treatment

Experimental

This is a single arm design. All subjects will be enrolled to have peripheral blood flow measured before, during, and after red light exposure.

干预措施: Red Light (670 nm energy) (Device)

Red Light treatment

Experimental

This is a single arm design. All subjects will be enrolled to have peripheral blood flow measured before, during, and after red light exposure.

干预措施: Octafluoropropane (Drug)

结局指标

主要结局

Changes in blood flow

时间窗: Baseline, 5 min of light, and up to 1 min after discontinuation of light

Video intensity units from contrast images will be converted to ml/min/g tissue

次要结局

  • Changes in nitric oxide metabolites(Baseline and 1 min after discontinuation of light)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicole Lohr

Professor

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验

Red Light Treatment in Peripheral Artery Disease | 临床试验